OTC: SHPMF - Shanghai Pharmaceuticals Holding Co., Ltd

Rentabilität für sechs Monate: +13.73%
Sektor: Healthcare

Aktionsplan Shanghai Pharmaceuticals Holding Co., Ltd


Über das Unternehmen

Shanghai Pharmaceuticals Holding Co., Ltd. researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including anti-tumor, heart and cerebral vessels, psychoneural, anti-infection, auto-immunity, digestive tract and metabolism, and respiratory system. It provides approximately 700 varieties of drugs.

weitere details
The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores, and online drug business. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.

EBITDA 75.53
EV/EBITDA 2.04
Industry Health Care Providers & Services
P/BV 0.1122
P/E 1.36
P/S 0.0297
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 1303.29
Див.доход ао 5.78
Дивиденд ао 0.4089
Сайт https://www.sphchina.com
Цена ао 1.49
Число акций ао 3.70129 млрд
Preisänderung pro Tag: 0% (1.64)
Preisänderung pro Woche: -2.67% (1.685)
Preisänderung pro Monat: -9.89% (1.82)
Preisänderung über 3 Monate: +0.6135% (1.63)
Preisänderung über sechs Monate: +13.73% (1.442)
Preisänderung pro Jahr: +5.81% (1.55)
Preisänderung über 3 Jahre: +4.46% (1.57)
Preisänderung über 5 Jahre: 0% (1.64)
Preisänderung über 10 Jahre: 0% (1.64)
Preisänderung seit Jahresbeginn: +29.13% (1.27)

Unterschätzung

Name Bedeutung Grad
P/S 0.1331 10
P/BV 0.0607 10
P/E 9.19 9
EV/EBITDA 12.31 7
Gesamt: 7.38

Effizienz

Name Bedeutung Grad
ROA, % 0.2504 1
ROE, % 0.7745 1
Gesamt: 0.8333

Dividenden

Name Bedeutung Grad
Div yield, % 4.36 10
DSI 0.7143 7.14
Gesamt: 6.9

Pflicht

Name Bedeutung Grad
Debt/EBITDA 26.99 0
Gesamt: 3.2

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % -80.15 0
Rentabilität Ebitda, % -83.73 0
Rentabilität EPS, % -89.94 0
Gesamt: 0

Dividende, % Dividende Basierend auf den Ergebnissen des Zeitraums Vorher kaufen Anmeldeschlussdatum Auszahlung vorher
0.67% 0.01 II кв. 2024 13.09.2024 17.09.2024 02.10.2024
5.39% 0.08 II кв. 2023 14.07.2023 18.07.2023 02.08.2023



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Bo Shen President, CFO, Head of the Accounting Department & Executive Director 804.26k 1973 (52 Jahr)
Mr. Yongzhong Li VP & Executive Director 904.39k 1970 (55 Jahre)
Mr. Tao Zhong VP, Board Secretary & Joint Company Secretary N/A 1972 (53 Jahr)
Mr. Dongming Li Vice President N/A 1969 (56 Jahre)
Ms. Shuai Shao Vice President N/A 1988 (37 Jahre)
Dr. Shunjiang Yu Chief Medical Officer N/A
Mr. Ming Dong Executive Director N/A 1976 (49 Jahre)
Ying Ke Director & General Manager of R&D Management Center N/A
Mr. Qiuhua Yang Executive Chairman N/A 1972 (53 Jahr)
Ms. Pui Kiu Wong Joint Company Secretary N/A

Adresse: China, Shanghai, Shanghai Pharmaceutical Building - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.sphchina.com